Neoral (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Neoral drug offered from Novartis Pharmaceuticals Corporation. This Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | cyclosporine |
| SUBSTANCE NAME: | CYCLOSPORINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1995-07-14 |
| END MARKETING DATE: | 0000-00-00 |
Neoral HUMAN PRESCRIPTION DRUG Details:
| Item Description | Neoral from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/mL) |
| START MARKETING DATE: | 1995-07-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0274_88a50d67-4f11-455f-bc5d-0a1d91bdcea8 |
| PRODUCT NDC: | 0078-0274 |
| APPLICATION NUMBER: | NDA050716 |
Other CYCLOSPORINE Pharmaceutical Manufacturers / Labelers:
